Copy-of-VA_National_Formulary_December_2015.xls
 Share
The version of the browser you are using is no longer supported. Please upgrade to a supported browser.Dismiss

View only
 
 
ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
DEPARTMENT OF VETERANS AFFAIRS
2
PHARMACY BENEFITS MANAGEMENT STRATEGIC HEALTH GROUP
3
http://www.pbm.va.gov/
4
http://vaww.pbm.va.gov
5
VHA NATIONAL FORMULARY
6
Dec-15
7
The VANF is dosage form specific. If a specific dosage form is not listed, the specific product in question should be considered non-formulary (although other dosage forms of that molecular entity may be included as formulary). Dosage forms such as TAB and CAP, ORAL are considered immediate release. Sustained release products are listed individually. Formulary products may also be available in many dosage forms and strengths. In the case of products with multiple dosage forms and strengths, not all forms and strengths need to be stocked. Facilities should make those dosages available that are necessary to meet their patient needs.”
8
9
PA- There are three levels of Prior Authorization
• Prior Authorization-National (PA-N) refers to medications that are formulary, but require prior approval at the national level before dispensing.
• Prior Authorization-VISN (PA-V) refers to medications that are formulary, but require prior approval at the VISN level before dispensing.
• Prior Authorization-Facility (PA-F) refers to medications that are formulary, but require prior approval at the facility level before dispensing.
Prior Authorization is used to insure that the medication is appropriate for each individual Veteran.
10
11
12
13
R The national restriction for antibiotics is that all decisions regarding which agents to carry in these classes will be made at the local or VISN level. These decisions should be based on local culture and sensitivity patterns. The restriction for all other products is as otherwise noted.
14
15
VA ClassRestrictionGenericDosage FormCommentsClinical GuidanceSpecial Handling
16
AM800RABACAVIRSOLN,ORAL
17
AM800RABACAVIRTAB
18
AM800RABACAVIR/DOLUTEGRAVIR/LAMIVUDINETABMonograph
19
AM800RABACAVIR/LAMIVUDINETAB
20
AM800RABACAVIR/LAMIVUDINE/ZIDOVUDINETAB
21
BL117ABCIXIMABINJ,SOLN
22
AD100ACAMPROSATETAB,ECClin Recs
23
HS502ACARBOSETAB
24
CN103ACETAMINOPHENI NJ
Restricted to post-op use and PACU areas
Criteriahttp://vaww.mirecc.va.gov/miamiproject/
25
CN103ACETAMINOPHENLIQUID,ORAL
26
CN103ACETAMINOPHENSUPP,RTL
27
CN103ACETAMINOPHENTAB
28
CN103ACETAMINOPHEN/BUTALBITAL/CAFFEINETAB
29
CN101ACETAMINOPHEN/HYDROCODONELIQUID,ORAL
30
CN101ACETAMINOPHEN/HYDROCODONETAB
31
CN101ACETAMINOPHEN/OXYCODONE HCLCAP,ORAL
32
CN101ACETAMINOPHEN/OXYCODONE HCLLIQUID,ORAL
33
CN101ACETAMINOPHEN/OXYCODONE HCLTAB
34
CV703ACETAZOLAMIDEINJ
35
CV703ACETAZOLAMIDETAB
36
IR100ACETIC ACIDSOLN,IRRG
37
OT109ACETIC ACID/ALUMINUM ACETATE SOLN,OTIC
38
OP102ACETYLCHOLINE CHLORIDESOLN,OPH
39
AD600ACETYLCYSTEINEINJ,SOLN
40
RE400ACETYLCYSTEINESOLN,INHL/ORAL
41
DE810ACITRETINCAP,ORALCriteria
42
AM800RACYCLOVIRCAP,ORAL
43
AM800RACYCLOVIRINJ
44
AM800RACYCLOVIRTAB
45
AM800RADEFOVIRTABRestricted to GI and ID
46
CV300ADENOSINEINJ,SOLN
47
XA603ADHESIVE AEROSOLSPRAY,TOP
48
XA603ADHESIVE CEMENTLIQUID,TOP
49
XA699ADHESIVE REMOVERLIQUID,TOP
50
OP900AFLIBERCEPTINJ.OPH
51
AP200ALBENDAZOLETAB
52
BL500ALBUMIN,HUMANINJ
53
RE102ALBUTEROLINHALANT
54
RE102ALBUTEROLSOLN,INHL
55
RE103ALBUTEROLTAB
56
RE109ALBUTEROL/IPRATROPIUMINHL,ORAL
57
RE109ALBUTEROL/IPRATROPIUMINHL,SOLN
58
DE101ALCOHOL ISOPROPYL 70% LIQUID,TOP
59
TN900ALCOHOL, ABSOLUTEINJ,SOLN
60
TN101ALCOHOL/DEXTROSEINJ
61
IM700ALDESLEUKININJ
62
HS900ALENDRONATETAB
63
CN101ALFENTANIL HCLINJ,SOLN
64
CV150ALFUZOSINTAB,SA
65
GA199ALGINIC AC/NA BICARB/CA STEAR/MG TRI (OTC)TAB,CHEWABLE
66
IM900ALLERGENIC EXTRACT (VARIOUS)INJ,SOLN
67
MS400ALLOPURINOLTAB
68
GA199ALOH/MG CARB/NA ALGINATE (OTC)TAB
69
GA199ALOH/MGOH/SIMTH (OTC)LIQUID,ORAL
70
CN302ALPRAZOLAMTAB
71
HS875ALPROSTADILINJ
72
HS875ALPROSTADIL URETHRALSUPPOSITORY
73
BL115ALTEPLASE, RECOMBINANTINJ,PWDR
74
DE450ALUMINUM CHLORIDE (HEXAHYDRATE)SOLN,TOP
75
GA101ALUMINUM HYDROXIDECAP,ORAL
76
GA101ALUMINUM HYDROXIDELIQUID,ORAL
77
DE900ALUMINUM SULFATE/CALCIUM ACETATE (OTC)POWDER,TOP
78
AM800RAMANTADINE HCLCAP/TABCriteria
79
AM800RAMANTADINE HCLSYRUPCriteria
80
AM300RAMIKACIN SULFATEINJ,SOLN
81
TN501AMINO ACIDSINJ,SOLN
82
TN501AMINO ACIDS/DEXTROSEINJ,SOLN
83
BL116AMINOCAPROIC ACIDINJ,SOLN
84
BL116AMINOCAPROIC ACIDTAB
85
RE104AMINOPHYLLINE DIHYDRATEINJ,SOLN
86
CV300AMIODARONEINJ,SOLN
87
CV300AMIODARONETAB
88
CN601AMITRIPTYLINE HCLTAB
89
CV200AMLODIPINETAB
90
CV400AMLODIPINE/BENAZEPRILCAP,ORALhttps://vaww.cmopnational.va.gov/cmop/PBM/Clinical Guidance/Forms/AllItems.aspx?RootFolder=%2Fcmop%2FPBM%2FClinical%20Guidance%2FClinical%20Recommendations&FolderCTID=0x0120006BA3B2280F536A41A2C5A1B0F4AFC943&View=%7b43999405-C9A2-47A4-AE17-15518717FA3E%25https://vaww.cmopnational.va.gov/cmop/PBM/Clinical Guidance/Forms/AllItems.aspx?RootFolder=%2Fcmop%2FPBM%2FClinical%20Guidance%2FDrug%20Monitoring&FolderCTID=0x0120006BA3B2280F536A41A2C5A1B0F4AFC943&View=%7b43999405-C9A2-47A4-AE17-15518717FA3E%7d
91
RE900AMMONIA,AROMATICINHL,NASAL
92
TN499AMMONIUM CHLORIDEINJ,SOLN
93
DE350AMMONIUM LACTATECREAM
94
DE350AMMONIUM LACTATELOTION
95
AM111RAMOXICILLINCAP,ORAL
96
AM111RAMOXICILLINPWDR,RENST-ORAL
97
AM111RAMOXICILLIN/CLAVULANATE KPWDR,RENST-ORAL
98
AM111RAMOXICILLIN/CLAVULANATE KTAB
99
CN801AMPHETAMINE/DEXTROAMPHETAMINE (EQV-ADDERALL)TAB
100
CN801
AMPHETAMINE/DEXTROAMPHETAMINE RESIN COMPLEX (EQV-ADDERALL XR)
CAP,SA
Loading...